[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20-22.[doi:10.3969/j.issn.1006-1959.2018.05.007]
　CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(05):20-22.[doi:10.3969/j.issn.1006-1959.2018.05.007]
点击复制

肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年05期
页码:
20-22
栏目:
出版日期:
2018-03-01

文章信息/Info

Title:
Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu
文章编号:
1006-1959（2018）05-0020-03
作者:
陈淑雯
上海市宝山区中西医结合医院内分泌科，上海 201900
Author(s):
CHEN Shu-wen
Department of Endocrinology,Shanghai Baoshan District Integrated Traditional Chinese and Western Medicine Hospital,Shanghai 201900,China
关键词:
肾衰宁; 科素亚; 糖尿病肾病
Keywords:
Key words：Shenshuaining; Kosu; Diabetic nephropathy
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2018.05.007
文献标志码:
A
摘要:
目的 观察肾衰宁联合科素亚治疗早期糖尿病肾病（DN）的临床疗效。方法 选取2016年1月~2017年1月我科收治确诊的早期DN患者80例，随机分为实验组和对照组，每组40例。对照组给予饮食宣教、运动、降血糖、调血脂等基础治疗并口服科素亚，实验组在对照组基础上口服肾衰宁片。比较治疗3个月后两组24h U-MA、BUN、Cr变化。结果 实验组治疗总有效率为85.00%，显著高于对照组的65.00%，差异有统计学意义（P＜0.05）；两组治疗后24h U-MA、BUN、Cr均显著低于治疗前，差异有统计学意义（P＜0.05）；实验组治疗后24h U-MA、BUN、Cr均显著低于对照组，差异有统计学意义（P＜0.05）。结论 在治疗早期糖尿病肾病方面，肾衰宁联合科素亚疗效显著，可减少尿蛋白，降低血尿素氮、血肌酐水平，可在临床大力推广。
Abstract:
Abstract：Objective To observe the clinical effect of Shenshuaining combined with Kosu in the treatment of early diabetic nephropathy.Methods From January 2016 to January 2017,80 patients with early DN were randomly divided into experimental group and control group,40 cases in each group.The control group was given diet education,exercise,hypoglycemia,blood lipids adjustment and so on basic treatment and oral Kosu,the experimental group on the basis of the control group oral Shenshuaining tablets,the 24 h U-MA,BUN,Cr changes of the two groups after 3 months were compared.Results The total effective rate of the experimental group was 85.00%,which was significantly higher than that of the control group 65.00%,the difference was significant(P<0.05),after two groups of treatment,24h U-MA,BUN,Cr were significantly lower than those before treatment,and the difference was statistically significant(P<0.05);the 24 h U-MA,BUN,Cr of the experimental group was significantly lower than that of the control group after treatment,the difference was statistically significant(P<0.05).Conclusion In the treatment of early diabetic nephropathy, Shenshuaining combined with Kosu has a significant effect,which can reduce urinary protein,blood urea nitrogen and serum creatinine level,and can be popularized in clinical practice.

参考文献/References:

[1]葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2014:524-532. [2]李栩,冯波.糖尿病肾病:亚洲糖尿病患者的状况和防治策略[J].中华临床医师杂志(电子版),2013,7(8):19-21. [3]吴瑞,崔文旺.益气养阴活血方治疗早期糖尿病肾病30例[J].河南中医,2013,33(11):1923-1924. [4]吴仁凯,王杰,徐清喜.黄葵胶囊联合缬沙坦治疗糖尿病肾病临床疗效探讨[J].中国生化药物杂志,2017,37(6):236-237. [5]胡婷,刘燕平,黄岑汉.中医药治疗糖尿病肾病研究进展[J].河南中医,2015,35(4):922-924. [6]朱俊利.黄葵胶囊联合缬沙坦治疗糖尿病肾病对肾功能及炎症因子的影响[J].现代中西医结合杂志,2017,26(17):1925-1938. [7]王云峰,张建平,林卫.厄贝沙坦联合阿托伐他汀治疗早期糖尿病肾病疗效及对肾功能和血清炎性因子的影响[J].中国药业,2017,26(10):69-71. [8]Dabhi B,Mistry KN.Oxidative stress and its association with TNF-ot 308 G/C and IL-1α-889 C／T gene polymorphisms in patients with diabetes and diabetic nephropathy[J].Gene,2015,562(2):197-202. [9]刘学清,高风,朱振娜,等.肾衰宁治疗慢性肾功能不全疗效观察[J].中国疗养医学,2014,23(4):335-336. [10]李百云,彭辉,熊东林,等.肾衰宁颗粒联合替米沙坦片治疗糖尿病肾病的疗效观察[J].中国中西医结合杂志,2015,35(2):138-142.

相似文献/References:

[1]王 娜,梁建庆,冯 鑫,等.基于网络药理学和分子对接探讨肾衰宁治疗糖尿病肾病的有效成分及作用机制[J].医学信息,2022,35(22):61.[doi:10.3969/j.issn.1006-1959.2022.22.010]
　WANG Na,LIANG Jian-qing,FENG Xin,et al.Study on Effective Components and Mechanism of Shenshuaining in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking[J].Journal of Medical Information,2022,35(05):61.[doi:10.3969/j.issn.1006-1959.2022.22.010]

更新日期/Last Update: 2018-03-01